Navigation Links
American Transplant Congress 2009
Date:3/23/2009

Experts Present New Research in Boston

MOUNT LAUREL, N.J. March 23 /PRNewswire/ -- The ninth annual American Transplant Congress 2009 (ATC) is the premier educational event in the field of basic and clinical transplantation. This joint meeting, sponsored by the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST), will occur from May 30 - June 4, 2009 at the John B. Hynes Convention Center in Boston, MA.

Controversial topics and important new data will be the focus of the Sunrise Symposia. Joint plenary sessions will showcase the top scoring abstracts, presented to the entire audience. On Sunday and Monday, there will be concurrent mid-day symposia centered on the timeliest issues in the field. "What's Hot, What's New" will be the final presentation.

ATC 09 will present two State-of-the-Art Addresses. Rudolf Jaenisch M.D., who established the Human Stem Cell Facility at the Whitehead Institute and is Professor of Biology at M.I.T., will speak on "Stem Cells and the Molecular Control of Pluripotency for Regenerative Medicine." Nobel prize winner, Philip Sharp M.D., Institute Professor at the David H. Koch Institute for Integrative Cancer Research at M.I.T. will present the topic of "RNA in Biology and Disease."

The meeting also features new, highly interactive sessions including the ATC New Investigator Career Highlight Forum. This discussion format will provide the opportunity for these individuals to introduce their research findings and obtain feedback from established investigators.

         ATC Highlights:
         State-of-the-Art Address - Rudolf Jaenisch M.D, M.I.T., Boston, MA
         State-of-the-Art Address - Philip Sharp, M.I.T., Boston, MA
         Special Interactive Sessions
         "What's Hot, What's New" Presentation
         Stem Cell & Islet Cell Research
         Infectious Diseases
         Cardiac Risks
         Living Donation
         Ethics, Economics & Regulatory Issues
         Incentives for Organ Donation
         New UNOS Pediatric Donor Allocation Policies
         Tissue Engineering
         Organ Allocation Worldwide
         Transplantation Controversies
         Biologic Immunosuppression Agents
         NanoMedicine
         ...many more crucial presentations

New worldwide research and discoveries will be presented through symposia, oral abstracts, concurrent workshops, poster presentations and small group sessions. Presenters include the most respected and knowledgeable individuals in transplantation science and medicine.

For more information about the American Society of Transplant Surgeons, visit www.asts.org. Learn more about the American Society of Transplantation at www.a-s-t.org. Visit www.atcmeeting.org for meeting schedule, key speakers, and more. Media interviews are encouraged.


'/>"/>
SOURCE American Transplant Congress 2009
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... Virginia (PRWEB) , ... February 06, 2016 , ... ... E-mail: amitchell(at)cee(dot)org , The Center for Excellence in Education Sponsors Teacher Training ... VA – February 4, 2016 – The Center for Excellence in Education (CEE) ...
(Date:2/5/2016)... Feb. 5, 2016  In the pharmaceutical industry the ... host of launch activities including the identification and engagement ... activity is especially high in the oncology therapeutic area ... Practices and the Role of Medical Affairs in Oncology ... on oncology therapies find better ways to utilize medical ...
(Date:2/5/2016)... , February 5, 2016 ... a biotechnology company focused on developing products for Regenerative ... requested Rare Pediatric Disease Designation (RPDD) from the US ... (RP) with MANF. MANF was previously granted orphan drug ... --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ... "Emotion Detection and Recognition Market by ... Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020" report ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition of ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
Breaking Biology News(10 mins):